Related Experiment Video
Updated: Oct 20, 2025

Intravascular Delivery of Biologics to the Rat Kidney
Published on: September 1, 2016
Buprenorphine blood concentrations: A biomarker for analgesia
1Johns Hopkins Neurosurgical Hunterian Laboratory, Baltimore, Maryland. ORCID: https://orcid.org/0000-0002-3079-6746.
Abstract:
Opioids, the frontline drugs for postsurgical analgesia, have been linked to diversion and abuse with lethal consequences. The search for safe analgesics with less harm potential has been decades long. However, clinical trials for safe opioid and nonopioid analgesics have relied on subjective pain reports, which are biased by placebo effects that increase the complexity of trials to develop new therapies to manage pain. Research in opioid naïve animals and humans demonstrates that blood concentrations of opioids that effectively saturate the morphine opioid receptor are tightly linked with patient reports and quantitative sensory tests for analgesia. Opioid drug concentrations can predict clinical responses. This report reviews preclinical and clinical evidence correlating buprenorphine pharmacokinetics with analgesia. More than 30 years of data confirm buprenorphine blood concentrations can be an objective biomarker of analgesia for moderate to severe acute postoperative pain.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Drug Concentrations: Measurements
Plasma...
Opioid Analgesics: Morphine and Other Natural Cogeners
Measurement of Bioavailability: Pharmacodynamic Methods
Measurement of Bioavailability: Pharmacokinetic Methods

